Kurz gefasst
Übersichtsarbeit in der Zeitschrift Digestion, 2024. Verfasst von Hidenori Tanaka und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan, hitanaka@hiroshima-u.ac.jp. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Endoscopic Mucosal Resection. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Background: Approximately 10% of patients with submucosal invasive (T1) colorectal cancer (CRC) have lymph node metastasis (LNM). The risk of LNM can be stratified according to various histopathological factors, such as invasion depth, lymphovascular invasion, histological grade, and tumor budding. Summary: T1 CRC with a low risk of LNM can be cured by local excision via endoscopic resection (ER), whereas surgical resection (SR) with lymph node dissection is required for high-risk T1 CRC. Current guidelines raise concern that many patients receive unnecessary SR, even though most patients achieve a radical cure. Novel diagnostic techniques for LNM, such as nomograms, artificial intelligence systems, and genomic analysis, have been recently developed to identify more low-risk T1 CRC cases. Assessing the curability and the necessity of additional treatment, including SR with lymph node dissection and chemoradiotherapy, according to histopathological findings of the specimens resected using ER, is becoming an acceptable strategy for T1 CRC, particularly for rectal cancer. Therefore, complete resection with negative vertical and horizontal margins is necessary for this strategy. Advanced ER methods for resecting the muscle layer or full thickness, which may guarantee complete resection with negative vertical margins, have been developed. Key Message: Although a necessary SR should not be delayed for T1 CRC given its unfavorable prognosis when SR with lymph node dissection is performed, the optimal treatment method should be chosen based on the risk of LNM and the patient’s life expectancy, physical condition, social characteristics, and wishes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan, hitanaka@hiroshima-u.ac.jp.
- Department of Gastroenterology, Hiroshima University Hospital, Hiroshima, Japan.
Zitieren
APA
Tanaka, H., Yamashita, K., Urabe, Y., Kuwai, T., & Oka, S. (2024). Management of T1 Colorectal Cancer. Digestion. https://doi.org/10.1159/000540594
Vancouver
Tanaka H, Yamashita K, Urabe Y, Kuwai T, Oka S. Management of T1 Colorectal Cancer. Digestion. 2024. doi:10.1159/000540594
BibTeX
@article{Tanaka2024,
author = {Tanaka, Hidenori and Yamashita, Ken and Urabe, Yuji and Kuwai, Toshio and Oka, Shiro},
title = {Management of T1 Colorectal Cancer},
journal = {Digestion},
year = {2024},
doi = {10.1159/000540594}
}
EUVIMED